USD 0.13
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -2.2 Million | -4.53 Million | -860.66 Thousand | -2.7 Million | -3.75 Million | -7.54 Million |
Net Income | 7.52 Million | -6.88 Million | -8.71 Million | -4.87 Million | -7.08 Million | -9.01 Million |
Depreciation & Amortization | 334.1 Thousand | 380.27 Thousand | 198.43 Thousand | 165.67 Thousand | 402.52 Thousand | 454.06 Thousand |
Deferred income taxes | -398.82 Thousand | -38.53 | -7351.00 | -44.47 Thousand | -50.42 Thousand | -25.94 Thousand |
Stock-based compensation | 167.9 Thousand | 38.53 Thousand | 1.21 Million | 471.64 Thousand | 1.1 Million | 474.85 Thousand |
Change in working capital | -22.2 Thousand | -2.35 Million | 856.73 Thousand | -483.72 Thousand | 754.19 Thousand | 194 Thousand |
Other non-cash items | -10.2 Million | 4.31 Million | 6.92 Million | 2.06 Million | 1.12 Million | 367.33 Thousand |
Investing Cash Flow | 11.51 Million | 1.77 Million | -1.59 Million | -7.9 Million | 68.07 Thousand | 404.02 Thousand |
Investments in PPE | -5.8 Million | -3.02 Million | -3.37 Million | -7.9 Million | - | - |
Acquisitions | 8.5 Million | -4804.55 | 79.2 Thousand | - | - | - |
Investment purchases | -17.31 Thousand | -327.76 Thousand | -1775.13 | - | - | - |
Sales/Maturities of investments | 8.81 Million | 5.13 Million | 1.69 Million | - | - | 404.02 Thousand |
Other Investing Activities | 17.31 Million | 4804.55 | 1.74 Million | - | - | 404.03 |
Financing Cash Flow | -6.95 Million | -73.53 Thousand | -37.84 Thousand | 17.26 Million | 4.18 Million | 6.35 Million |
Debt repayment | -4.84 Million | -73.53 Thousand | -2.8 Million | -2.8 Million | -40.84 Thousand | -2.5 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 663.19 Thousand | - | - | 4.58 Million | 3.1 Million | 3.38 Million |
Other Financing Activities | -2.1 Million | -73.53 | 10.18 Million | 15.48 Million | 1.12 Million | 2.97 Million |
Accounts receivables | -15.79 Thousand | 65.62 Thousand | 283.48 Thousand | 157.24 Thousand | 157.24 Thousand | -4.03 |
Accounts payables | - | -2.58 Million | - | -511.26 Thousand | - | - |
Inventory | - | - | - | 511.26 Thousand | - | - |
Other working capital | -6408.00 | 163.66 Thousand | 573.25 Thousand | -640.97 Thousand | 596.95 Thousand | 194.01 Thousand |
Cash at beginning of period | 348.37 Thousand | 3.11 Million | 378.33 Thousand | 378.33 Thousand | 446.47 Thousand | 1.03 Million |
Cash at end of period | 2.7 Million | 348.37 Thousand | 3.11 Million | 6.79 Million | 378.33 Thousand | 446.47 Thousand |
Capital Expenditure | -5.8 Million | -3.02 Million | -3.37 Million | -7.9 Million | - | - |
Effect of forex changes on cash | -6392.00 | 69.33 Thousand | -1.33 Million | -236.31 Thousand | -506.78 Thousand | 195.63 Thousand |
Net cash flow / Change in cash | 2.35 Million | -2.76 Million | 2.73 Million | 6.41 Million | -68.14 Thousand | -588.77 Thousand |
Free Cash Flow | -8 Million | -7.56 Million | -4.23 Million | -10.6 Million | -3.75 Million | -7.54 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -256.23 Thousand | -881.29 Thousand | 7.86 Million | 7.48 Million | -7.73 Million | -6494.00 |
Depreciation & Amortization | 40.38 Thousand | 48.09 Thousand | 191.43 Thousand | 105.87 Thousand | 24.2 Thousand | 87.63 Thousand |
Deferred income taxes | - | - | -398.82 Thousand | -15.14 Thousand | 6.75 Million | -141.04 |
Stock-based compensation | 10.41 Thousand | 35.09 Thousand | 167.9 Thousand | 4315.00 | 3473.00 | 141.03 Thousand |
Change in working capital | -172.92 Thousand | -57.93 Thousand | -1.34 Million | -79.82 Thousand | 223.06 Thousand | -478.29 Thousand |
Other non-cash items | 167.8 Thousand | 742.47 Thousand | -11.27 Million | -19.12 Million | 233.44 Thousand | 50.4 Thousand |
Investing Cash Flow | -533.72 Thousand | -510.56 Thousand | 11.51 Million | 8.28 Million | 8.01 Million | -847.18 Thousand |
Investments in PPE | -533.72 Thousand | -510.56 Thousand | -5.8 Million | -532.84 Thousand | -482.21 Thousand | -847.18 Thousand |
Acquisitions | - | - | 8.5 Million | - | 8.5 Million | - |
Investment purchases | - | - | -17.31 Thousand | - | 1454.00 | - |
Sales/Maturities of investments | - | - | 8.81 Million | 8.81 Million | -8.5 Million | - |
Other Investing Activities | - | - | 17.31 Million | 8.81 Million | 8.5 Million | - |
Financing Cash Flow | -19.96 Thousand | -29.05 Thousand | -4.18 Million | -2.76 Million | -40.83 Thousand | -27.75 Thousand |
Debt repayment | -19.96 Thousand | -29.05 Thousand | -4.73 Million | -2.73 Million | -35.56 Thousand | -21.71 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | -5.26 | - |
Common Stock Issuance | - | - | 663.19 Thousand | - | -5264.00 | -6040.00 |
Other Financing Activities | - | - | -2.1 Million | -5.52 Million | -5264.00 | -6040.00 |
Accounts receivables | -12.14 Thousand | - | -15.79 Thousand | -15.18 Thousand | 110.28 Thousand | -83.92 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -160.77 Thousand | -57.93 Thousand | -1.33 Million | -64.64 Thousand | 112.78 Thousand | -394.37 Thousand |
Cash at beginning of period | 1.92 Million | 2.7 Million | 348.37 Thousand | 8.92 Million | 1.42 Million | 2.66 Million |
Cash at end of period | 1.05 Million | 1.92 Million | 2.7 Million | 2.7 Million | 8.92 Million | 1.42 Million |
Capital Expenditure | -533.72 Thousand | -510.56 Thousand | -5.8 Million | -532.84 Thousand | -482.21 Thousand | -847.18 Thousand |
Effect of forex changes on cash | -3074.00 | 6513.00 | -6392.00 | -4459.00 | 22.55 Thousand | -23.6 Thousand |
Net cash flow / Change in cash | -870.65 Thousand | -777.95 Thousand | 2.35 Million | -6.22 Million | 7.5 Million | -1.24 Million |
Free Cash Flow | -847.61 Thousand | -755.41 Thousand | -10.77 Million | -12.27 Million | -978.69 Thousand | -1.19 Million |
KARURVYSYA
STKS
STMPA
8869
FNQQF
VENUSREM